CMS Reveals Limited Digital Health Policies in Final Medicare Rule


In a move that has drawn considerable attention just days before the 2024 presidential election, the Centers for Medicare & Medicaid Services (CMS) has released the final calendar year 2025 physician fee schedule (PFS) rule. This rule, which impacts digital therapeutics, telehealth, rural health clinics, and opioid treatment programs, underscores CMS’s limited authority in shaping digital health payment policies.
Digital Health Policies
CMS has finalized several digital health policies, as initially proposed in July’s draft rule. However, the offerings remain modest. New codes have been introduced for digital therapeutics, particularly aimed at mental healthcare. These changes mainly involve redefining existing codes to distinguish them from remote therapeutic monitoring codes. CMS’s authority in this area is limited, prompting a call for congressional action to create a new benefit category for digital therapeutics.
Telehealth Policies
With the expiration of Medicare telehealth flexibilities looming at the end of 2024, CMS has highlighted the necessity for Congress to extend key telehealth waivers. These waivers have significantly expanded telehealth services since 2020. Permanent coverage for audio-only visits and direct supervision via telehealth has been confirmed, yet geographical and origin site restrictions continue to pose challenges. For further details, you can refer to the original article.
Rural Health Clinics and Federally Qualified Health Centers
CMS has been striving to achieve payment parity for telehealth services compared to in-person services in rural health clinics and federally qualified health centers. While a special payment rate is applied for telehealth, CMS has opted to retain its current payment methodology for now, though reforms may be considered in the future.
Opioid Treatment Programs
The rule acknowledges the importance of telehealth in opioid treatment programs, especially for older Medicare beneficiaries who rely heavily on audio-only services. CMS will allow telehealth usage for periodic assessments, marking a step forward in addressing opioid use disorder through digital means.
For a comprehensive understanding of the finalized rule and its implications, visit the CMS Federal Register.

Conclusion


While CMS has made some progress, the agency emphasizes the need for congressional action to broaden and secure these developments. The future of digital health policies remains uncertain, with much depending on legislative support.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.